These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 32503850)
21. Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo Mathian A; Amoura Z Ann Rheum Dis; 2021 May; 80(5):e78. PubMed ID: 32759253 [No Abstract] [Full Text] [Related]
22. Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar Mathian A; Amoura Z Ann Rheum Dis; 2021 Apr; 80(4):e57. PubMed ID: 32513651 [No Abstract] [Full Text] [Related]
23. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic. Peschken CA J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064 [No Abstract] [Full Text] [Related]
24. Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli Romão VC; Cruz-Machado AR; Fonseca JE Ann Rheum Dis; 2021 May; 80(5):e76. PubMed ID: 32561609 [No Abstract] [Full Text] [Related]
25. [Rheumatology update 2020: the focus was on Covid-19]. Hügle T Rev Med Suisse; 2021 Jan; 17(723):214-218. PubMed ID: 33507664 [TBL] [Abstract][Full Text] [Related]
26. Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries. Ziadé N; El Kibbi L; Hmamouchi I; Abdulateef N; Halabi H; Hamdi W; Abutiban F; El Rakawi M; Eissa M; Masri B Int J Rheum Dis; 2020 Nov; 23(11):1550-1557. PubMed ID: 32892516 [TBL] [Abstract][Full Text] [Related]
27. COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic. Akintayo RO; Akpabio A; Kalla A; Dey D; Migowa A; Olaosebikan H; Bahiri R; El Miedany Y; Hadef D; Hamdi W; Oyoo O; Slimani S; Yerima A; Taha Y; Adebajo A; Adelowo O; Tikly M; Ghozlani I; Abdelghani KB; Fouad NA; Mosad D; El Mikkawy D; Abu-Zaid MH; Abdel-Magied RA; Ann Rheum Dis; 2021 Jun; 80(6):e100. PubMed ID: 32611599 [No Abstract] [Full Text] [Related]
28. Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America. González-Rangel J; Pérez-Muñoz B; Casillas-Santos D; Barrera-Vargas A; Vázquez-Cardenas P; Escamilla-Santiago R; Merayo-Chalico J Lupus; 2021 Oct; 30(12):1879-1887. PubMed ID: 34459303 [TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine retinopathy - implications of research advances for rheumatology care. Jorge A; Ung C; Young LH; Melles RB; Choi HK Nat Rev Rheumatol; 2018 Dec; 14(12):693-703. PubMed ID: 30401979 [TBL] [Abstract][Full Text] [Related]
30. Patients with lupus with COVID-19: University of Michigan experience. Wallace B; Washer L; Marder W; Kahlenberg JM Ann Rheum Dis; 2021 Mar; 80(3):e35. PubMed ID: 32475835 [No Abstract] [Full Text] [Related]
31. Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace Mathian A; Amoura Z Ann Rheum Dis; 2021 Mar; 80(3):e36. PubMed ID: 32475832 [No Abstract] [Full Text] [Related]
32. Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis. Spinelli FR; Ceccarelli F; Di Franco M; Conti F Ann Rheum Dis; 2021 Jan; 80(1):e9. PubMed ID: 32366521 [No Abstract] [Full Text] [Related]
33. Rheumatic disease and COVID-19. Liew JW; Graef ER Ann Rheum Dis; 2021 Mar; 80(3):e43. PubMed ID: 32651196 [No Abstract] [Full Text] [Related]
34. Evaluation of pediatric rheumatology telehealth satisfaction during the COVID-19 pandemic. Waqar-Cowles LN; Chuo J; Weiss PF; Gmuca S; LaNoue M; Burnham JM Pediatr Rheumatol Online J; 2021 Dec; 19(1):170. PubMed ID: 34886863 [TBL] [Abstract][Full Text] [Related]
35. How did COVID-19 pandemic changed the Portuguese rheumatology? Vieira-Sousa E; Fonseca JE; Santos MJ Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820 [No Abstract] [Full Text] [Related]
37. Therapy for childhood rheumatic diseases. Have we been doing enough? Schaller JG Arthritis Rheum; 1993 Jan; 36(1):65-70. PubMed ID: 8424838 [No Abstract] [Full Text] [Related]
38. How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study. Pugliesi A; Sachetto Z; de Medeiros Pinheiro M; Salviato Pileggi G; Sarot Pereira da Cunha G; Hajar FN; Marques Negrisolli Cunha ML; Henrique da Mota LM; Lopes Marques CD; Kakehasi AM; Rodrigues Ferreira WH; Araújo NC; Monteiro Gomides Reis AP; Rodrigues de Abreu Vieira RM; Ferreira GA; Danowski A; de Souza VA; Soares Egypto de Brito DC; Dos Santos Paiva E; Provenza JR; Feijó Azevedo V J Clin Rheumatol; 2024 Jan; 30(1):e29-e33. PubMed ID: 35699528 [TBL] [Abstract][Full Text] [Related]
39. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic. Parperis K Ann Rheum Dis; 2021 Jan; 80(1):e8. PubMed ID: 32321722 [No Abstract] [Full Text] [Related]